Bioresorbable metal scaffold for cardiovascular application: current knowledge and future perspectives

Area of Science:

• Cardiovascular medicine
• Biomaterials science
• Interventional cardiology

Background:

• Drug-eluting stents have significantly lowered restenosis rates but remain permanent implants.
• Concerns about the long-term presence of metallic stents have driven research into alternatives.
• Bioresorbable scaffolds aim to provide temporary support and then disappear, mimicking natural tissue.

Purpose of the Study:

• To review the current state of bioresorbable metal scaffolds (BMS).
• To discuss the application of metal alloys in the development of temporary cardiovascular scaffolds.
• To summarize preclinical and clinical findings related to BMS.

Main Methods:

• Literature review of studies on bioresorbable metal scaffolds.
• Analysis of preclinical data on scaffold performance and biocompatibility.
• Evaluation of clinical trial outcomes for safety and efficacy.

Main Results:

• Bioresorbable metal scaffolds show potential in reducing restenosis and the need for revascularization.
• Metal alloys are being investigated for their degradation profiles and mechanical properties in scaffolds.
• Early clinical data suggest feasibility and acceptable safety of BMS.

Conclusions:

• Bioresorbable metal scaffolds represent a significant advancement over permanent metallic stents.
• Further research and clinical validation are needed to establish BMS as a standard treatment.
• The development of BMS addresses the limitations associated with permanent cardiovascular implants.